Sonnet BioTherapeutics (SONN) Revenue & Revenue Breakdown
Sonnet BioTherapeutics Revenue Highlights
Latest Revenue (Y)
$147.81K
Main Segment (Y)
Better Burgers Fast Casual
Main Geography (Y)
United States
Sonnet BioTherapeutics Revenue by Period
Sonnet BioTherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $147.81K | -57.76% |
| 2022-09-30 | $349.94K | -27.64% |
| 2021-09-30 | $483.63K | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2019-09-30 | $40.61M | 32.15% |
| 2018-12-31 | $30.73M | -25.82% |
| 2017-12-31 | $41.43M | -0.65% |
| 2016-12-31 | $41.70M | -1.64% |
| 2015-12-31 | $42.40M | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $17.50M | - |
Sonnet BioTherapeutics generated $147.81K in revenue during NA 2023, up -57.76% compared to the previous quarter, and up 0.48% compared to the same period a year ago.
Sonnet BioTherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $1.00M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $18.63K | -50.00% |
| 2023-09-30 | $37.26K | 1.10% |
| 2023-06-30 | $36.85K | 1.11% |
| 2023-03-31 | $36.45K | -2.17% |
| 2022-12-31 | $37.26K | -40.63% |
| 2022-09-30 | $62.75K | 1.10% |
| 2022-06-30 | $62.07K | -34.88% |
| 2022-03-31 | $95.32K | -26.56% |
| 2021-12-31 | $129.80K | -73.16% |
| 2021-09-30 | $483.63K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2020-09-30 | $-5.68M | 100.00% |
| 2020-06-30 | - | -100.00% |
| 2020-03-31 | $5.68M | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2019-09-30 | $9.65M | -9.87% |
| 2019-06-30 | $10.71M | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2018-09-30 | $10.10M | -2.90% |
| 2018-06-30 | $10.40M | 4.05% |
| 2018-03-31 | $10.00M | -0.86% |
| 2017-12-31 | $10.08M | -6.00% |
| 2017-09-30 | $10.73M | -0.37% |
| 2017-06-30 | $10.77M | 9.18% |
| 2017-03-31 | $9.86M | -10.17% |
| 2016-09-30 | $10.98M | 2.09% |
| 2016-06-30 | $10.75M | 4.68% |
| 2015-09-30 | $10.27M | -4.83% |
| 2015-06-30 | $10.79M | 12.12% |
| 2014-09-30 | $9.63M | 39.12% |
| 2014-06-30 | $6.92M | 330.81% |
| 2013-09-30 | $1.61M | -3.65% |
| 2013-03-31 | $1.67M | -5.68% |
| 2012-09-30 | $1.77M | - |
Sonnet BioTherapeutics generated - in revenue during Q2 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Sonnet BioTherapeutics Revenue Breakdown
Sonnet BioTherapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 18 |
|---|---|
| Hooters Full Service | $13.84M |
| Better Burgers Fast Casual | $22.62M |
| Just Fresh Fast Casual | $4.05M |
| Corporate and Other | $100.00K |
Sonnet BioTherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 18: Better Burgers Fast Casual (55.69%), Hooters Full Service (34.08%), Just Fresh Fast Casual (9.98%), and Corporate and Other (0.25%).
Quarterly Revenue by Product
| Product/Service | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|
| Hooters Full Service | $2.89M | $3.34M | $3.35M | $3.41M | $3.39M | $3.51M |
| Better Burgers Fast Casual | $5.82M | $6.33M | $5.86M | $5.76M | $5.69M | $5.80M |
| Just Fresh Fast Casual | $943.52K | $1.01M | $967.88K | $926.05K | $989.10K | $1.06M |
| Corporate and Other | $50.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K |
Sonnet BioTherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 19: Better Burgers Fast Casual (60.02%), Hooters Full Service (29.74%), Just Fresh Fast Casual (9.72%), and Corporate and Other (0.52%).
Sonnet BioTherapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 18 |
|---|---|
| Europe | $2.86M |
| South Africa | $5.83M |
| United States | $31.93M |
Sonnet BioTherapeutics's latest annual revenue breakdown by geography, as of Dec 18: United States (78.62%), South Africa (14.34%), and Europe (7.04%).
Quarterly Revenue by Country
| Country | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|
| United States | $7.64M | $8.65M | $8.15M | $7.95M | $8.04M | $8.16M |
| Just Fresh Fast Casual | $943.52K | - | - | - | - | - |
| Hooters Full Service | $2.89M | - | - | - | - | - |
| Corporate and Other | - | - | - | - | - | - |
| Better Burgers Fast Casual | $5.82M | - | - | - | - | - |
| South Africa | $1.38M | $1.35M | $1.39M | $1.50M | $1.35M | $1.47M |
| Europe | $634.41K | $709.73K | $652.73K | $670.11K | $707.51K | $768.00K |
Sonnet BioTherapeutics's latest quarterly revenue breakdown by geography, as of Sep 19: United States (39.55%), Better Burgers Fast Casual (30.16%), Hooters Full Service (14.95%), South Africa (7.17%), Just Fresh Fast Casual (4.89%), and Europe (3.29%).
Sonnet BioTherapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CASI | CASI Pharmaceuticals | $33.88M | $3.41M |
| CLGN | CollPlant Bio | $10.96M | $98.00K |
| SABS | SAB Biotherapeutics | $2.24M | - |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| ENTO | Entero Therapeutics | - | - |
| BOLD | Boundless Bio | - | - |
| KZR | Kezar Life Sciences | - | - |
| LPTX | Leap Therapeutics | - | - |
| PASG | Passage Bio | - | - |
| CVKD | Cadrenal Therapeutics | - | - |
| TAOX | TAO Synergies | - | - |